Cardiologists employed by a hospital appear to be more likely to pursue cardiac catheterization or angioplasty than independent cardiologists.

The device, described as the "world's smallest heart pump," has received the FDA's breakthrough device designation for two indications. 

Two known leaders in the field of preventive cardiology—Martha Gulati, MD, and Erin D. Michos, MD—contributed to a new analysis of heart-healthy diets and CVD.

This represents the third significant addition to US Heart and Vascular's practice management platform in a matter of weeks.

Gulati, known for her work in the field of preventive cardiology, is also being recognized for her role in the development of the 2021 chest pain guidelines. 

The healthcare technology company, previously known as Angel Medical Systems, is merging with BIOS Acquisition Corporation to form a new publicly traded company.

Casana, the company behind the Heart Seat, is now pursuing approvals for additional indications. 

The two new leadless pacemakers, the Micra AV2 and Micra VR2, feature much longer batteries than previous models. 

Two experienced TAVR specialists—Sachin Goel, MD, and Michael Reardon, MD—examined the growing trend of younger, low-risk patients being recommended for TAVR over SAVR.

The new-look device, which captures ECG and seismocardiogram measurements at the same time, is completely wireless and runs on batteries that last up to 40 hours.